Shinva Medical Instrument Co Ltd
SSE:600587

Watchlist Manager
Shinva Medical Instrument Co Ltd Logo
Shinva Medical Instrument Co Ltd
SSE:600587
Watchlist
Price: 13.59 CNY -2.51% Market Closed
Market Cap: ¥8.2B

Shinva Medical Instrument Co Ltd
Change in Working Capital

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Shinva Medical Instrument Co Ltd
Change in Working Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
Shinva Medical Instrument Co Ltd
SSE:600587
Change in Working Capital
-¥2.3B
CAGR 3-Years
-5%
CAGR 5-Years
-7%
CAGR 10-Years
-7%
A
APT Medical Inc
SSE:688617
Change in Working Capital
-¥1B
CAGR 3-Years
-26%
CAGR 5-Years
-34%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Change in Working Capital
-¥2.9B
CAGR 3-Years
-13%
CAGR 5-Years
-11%
CAGR 10-Years
-21%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Change in Working Capital
-¥10.6B
CAGR 3-Years
-12%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Andon Health Co Ltd
SZSE:002432
Change in Working Capital
-¥730.9m
CAGR 3-Years
10%
CAGR 5-Years
-12%
CAGR 10-Years
-8%
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Change in Working Capital
-¥3.9B
CAGR 3-Years
-28%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
No Stocks Found

Shinva Medical Instrument Co Ltd
Glance View

Market Cap
8.2B CNY
Industry
Health Care

In the brisk hustle of China's healthcare evolution, Shinva Medical Instrument Co., Ltd. stands as a pivotal player, navigating the intricate world of medical devices and pharmaceutical machinery since its inception in 1943. Rooted deeply in the tangible yet transformative realm of healthcare technology, Shinva has advanced from its initial focus on producing pharmaceutical sterilization equipment to a comprehensive provider of medical solutions. With its headquarters in the tech-driven province of Shandong, Shinva operates in various sectors, providing a multifaceted approach to healthcare. The company’s operations span across diverse segments including medical devices, environmental protection equipment, and pharmaceutical engineering services, ensuring it remains adaptive to contemporary medical demands and regulatory standards. Revenue flows primarily from the design, manufacture, and distribution of medical and laboratory equipment, widening its customer base from local hospitals to international healthcare facilities. Shinva’s portfolio is intriguingly broad, encompassing products that range from high-end sterilization tools and radiation therapy equipment to diagnostic imaging and surgical instruments. This diversification safeguards the company against market volatility while aligning with the ever-increasing demand for efficiency and safety in medical procedures. Moreover, its commitment to research and development underscores its strategic mission to innovate and refine healthcare delivery systems, anchoring its status as a leader in the industry. This adaptability and relentless pursuit of quality enable Shinva to thrive, aptly positioning it to grow alongside China's expansive healthcare sector.

Intrinsic Value
27.41 CNY
Undervaluation 50%
Intrinsic Value
Price ¥13.59

See Also

What is Shinva Medical Instrument Co Ltd's Change in Working Capital?
Change in Working Capital
-2.3B CNY

Based on the financial report for Sep 30, 2025, Shinva Medical Instrument Co Ltd's Change in Working Capital amounts to -2.3B CNY.

What is Shinva Medical Instrument Co Ltd's Change in Working Capital growth rate?
Change in Working Capital CAGR 10Y
-7%

Over the last year, the Change in Working Capital growth was -3%. The average annual Change in Working Capital growth rates for Shinva Medical Instrument Co Ltd have been -5% over the past three years , -7% over the past five years , and -7% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett